glp-1 litigation news today Thousands of patients are suing the companies behind weight loss drugs, alleging they caused blindness, loss of brain function and organ damage. Jonathan Orent, an attorney representing some of the plaintiffs, GLP-1 Law & Policy
Description
Continuing this discussion, we broaden the lens to the developing litigation environment and additional regulatory scrutiny that can affect manufacturers, pharmacies, telehealth providers, and other stakeholders across the GLP1 ecosystem
Estimate your daily protein target on GLP-1 medications like Ozempic, Mounjaro, Wegovy, and Zepbound
Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.
Understanding their models helps patients make informed decisions about which platform aligns with their treatment goals
